Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Democrats take aim at big companies in economic blueprint

Published 07/24/2017, 04:53 PM
Updated 07/24/2017, 04:53 PM
© Reuters. Democrats unveil the Democratic party's "A Better Deal" for working Americans in Berryville

By Amanda Becker

WASHINGTON (Reuters) - U.S. Democrats unveiled an economic platform on Monday that included plans to address unfair market competition, rising pharmaceuticals costs and stagnant wages.

Democrats proposed new standards that companies must meet to complete large mergers and enhanced post-merger reviews, singling out the airline, telecommunications, beer, food and eyeglass industries as areas of concern in the proposal dubbed "A Better Deal" for working Americans.

Last year, Republicans proposed legislative goals with a similar title: "A Better Way."

The Democrats' platform is a move to regroup ahead of the 2018 midterm congressional elections, after Hillary Clinton's loss to Republican President Donald Trump in 2016. Republicans control both the House and the Senate.

Senator Chuck Schumer, the top Democrat in the U.S. Senate, accused Trump of running a populist election campaign and then abandoning working people for special interests once in the White House.

"We can't delude anyone that this Congress will begin passing our priorities tomorrow but we have to start presenting our vision for the country's future," Schumer said at a kickoff event in the town of Berryville, Virginia.

Accompanying Schumer was House Minority Leader Nancy Pelosi, Senators Elizabeth Warren, Chris Van Hollen and Amy Klobuchar, and Representatives Hakeem Jeffries and David Cicilline, among others.

Democrats want to create an independent government agency that would crack down on drug companies that raise prices excessively. They also want to allow Medicare, the government health insurance program for the elderly, to negotiate prices with manufacturers.

Additionally, drug companies would need to justify big price hikes to the government.

Policy proposals provided to reporters singled out a few companies by name, including Turing Pharmaceuticals and Valeant Pharmaceuticals International Inc (NYSE:VRX).

One document criticized United Continental Holdings Inc for the "brutal assault" of a United passenger who was already seated on an overbooked flight and refused to give up his seat for a crew member.

Separately, if AT&T (NYSE:T) Inc's purchase of Time Warner Inc (NYSE:TWX) succeeds, it would allow the "resulting behemoths" to "unfairly discriminate" against smaller distributors, one document stated.

When Anheuser Busch InBev, the world's largest beer maker, purchased SABMiller (LON:SAB), the second-largest beer company, it put smaller brewers at a disadvantage, the documents said.

Mergers between Dow Chemical (NYSE:DOW) Co and DuPont (NYSE:DD), Monsanto (NYSE:MON) Co with Bayer AG (DE:BAYGN) and Syngenta AG (SIX:SYNN) with ChemChina "threaten the safety of food and agriculture in America," one document said.

© Reuters. Democrats unveil the Democratic party's "A Better Deal" for working Americans in Berryville

Democrats will also propose doubling federal support for apprenticeship programs, a tax credit for employers that hire and train workers that make a liveable wage, and encouraging partnerships between companies and public high schools and community colleges.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.